Li, Xiang-Yang <br/><br/>
How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.  [electronic resource] 

 -  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy  Jun 2010 
 - 308-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1744-9987 
<br/><br/><label>Standard No.: </label>10.1111/j.1744-9987.2009.00783.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimicrobial Cationic Peptides--blood<br/>C-Reactive Protein--metabolism<br/>Case-Control Studies<br/>Female<br/>Hepcidins<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Interleukin-6--blood<br/>Kidney Failure, Chronic--therapy<br/>Male<br/>Middle Aged<br/>Protein Precursors--blood<br/>Renal Dialysis<br/>Simvastatin--pharmacology<br/>Young Adult